HBM Holdings Limited (HKG:2142)
Hong Kong · Delayed Price · Currency is HKD 11.75
-0.12 (-1.01%)
May 27, 2026, 4:09 PM HKT
HBM Holdings Market Cap
HBM Holdings has a market cap or net worth of 10.2 billion as of May 27, 2026. Its market cap has increased by 46.56% in one year.
Market Cap
10.20B
Enterprise Value
7.69B
Revenue
1.23B
Ranking
n/a
PE Ratio
13.72
Stock Price
11.75
Market Cap Chart
Since December 10, 2020, HBM Holdings's market cap has increased from 8.46B to 10.20B, an increase of 20.48%. That is a compound annual growth rate of 3.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 27, 2026 | 10.20B | 0.29% |
| Dec 31, 2025 | 10.17B | 646.15% |
| Dec 31, 2024 | 1.36B | -3.91% |
| Dec 29, 2023 | 1.42B | -32.16% |
| Dec 30, 2022 | 2.09B | -63.14% |
| Dec 31, 2021 | 5.67B | -30.06% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 10, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ascentage Pharma Group International | 15.33B |
| CStone Pharmaceuticals | 12.82B |
| Nanjing Leads Biolabs | 12.76B |
| Everest Medicines | 11.17B |
| CARsgen Therapeutics Holdings | 9.43B |
| Alphamab Oncology | 9.06B |
| Shanghai Haohai Biological Technology | 8.35B |
| Lepu Biopharma | 8.26B |